TCO ODOLEX SHADOW 150G AMBROXOL-DEXTROMETORFANO PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA

Description

PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA 10/20

30 ML Crema Envase

La dosis y duración del tratamiento deben ser determinadas por el médico

1 jeringa prellenada con 0

FORMA FARMACÉUTICA: 1 LIQUIDO

TCO ODOLEX SHADOW 150G AMBROXOL-DEXTROMETORFANO PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy